Dynavax Technologies Corp.
Sector: Manufacturing
Industry: Pharmaceutical Products
9.67
0.16
(1.68%)
Volume:
1,573,606
52 week range:
9.22 - 14.63
Market Cap:
1.161B
Company Description:
The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in the vaccine. The company was formerly known as Double Helix Corporation.